Lehigh Valley Health Network Selects StudyManager Reveal for Clinical Trial Management
StudyManager announced that Lehigh Valley Health Network selected StudyManager’s Reveal software to manage its clinical trials.
As a health network that includes three hospital facilities, nine health centers, and numerous primary and specialty care physician practices located throughout the state of Pennsylvania, Lehigh Valley Health Network sought a solution to centralize activity across multiple facilities and departments. Billing and protocol compliance, financial accountability, patient tracking, and high-level reporting for management oversight were all important criteria in selecting a CTMS system. Following an in-depth review process, Lehigh Valley selected StudyManager Reveal.
“We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data across our many research departments,” said Eric Mueller, MSA, Director of Research Administration, Lehigh Valley Health Network. “After evaluating several CTMS systems, we felt that StudyManager Reveal provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, and financial requirements.”
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
